Emily J Culme-Seymour

Author

Also Known As

Culme-Seymour, E, E.J. Culme-Seymour, Emily Culme-Seymour, Emily J Culme-Seymour, Emily J. Culme-Seymour, Emily J. Culme-Seymour

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University College London Harvard Stem Cell Institute

About

Emily J Culme-Seymour is an author at University College London specializing in medicine, cell transplantation, and regenerative medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	298
2	Engineering	3	3	213
3	Biomedical Engineering	3	3	213
4	Cellular Therapies	3	3	99
5	Cell Biology	1	1	14

Emily J Culme-Seymour

Publications

555

Citations

H-Index

Page 1

	Year	Citations
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study Francesca Ferrua, Maria Pia Cicalese, Stefania Galimberti, The Lancet Haematology	2019	200
Tissue-Engineered Tracheal Replacement in a Child: A 4-Year Follow-Up Study Nicholas Hamilton, Mazyar Kanani, Derek Roebuck, American Journal of Transplantation Tissue EngineeringLung TransplantationEngineeringHeartlung TransplantTissue-engineered Trachea	2015	175
A Decade of Cell Therapy Clinical Trials (2000–2010) Emily J Culme-Seymour, Natasha L. Davie, David Brindley, Regenerative Medicine Cell TherapyCellular TherapiesMedicineImmunologyClinical Trials	2012	66
Study Design: Human Leukocyte Antigen Class I Molecule A∗02-Chimeric Antigen Receptor Regulatory T Cells in Renal Transplantation Katharina Schreeb, Emily J Culme-Seymour, Essra Ridha, Kidney International Reports	2022	57
Cost of Stem Cell-Based Tissue-Engineered Airway Transplants in the United Kingdom: Case Series Emily J Culme-Seymour, Katrina Mason, Laura Vallejo‐Torres, Tissue Engineering Part A Tissue EngineeringEngineeringCase SeriesTissue TransplantationUnited Kingdom	2015	24
Cell Therapy Companies Make Strong Progress from October 2012 to March 2013 Amid Mixed Stock Market Sentiment Chris Mason, J. Mason, Emily J Culme-Seymour, Cell stem cell Cell TherapyMarch 2013OncologyCellular TherapiesOctober 2012	2013	19
Promising Growth and Investment in the Cell Therapy Industry during the First Quarter of 2012 David Brindley, Natasha L. Davie, William A. Sahlman, Cell stem cell Regenerative MedicineFirst QuarterTranslational MedicineCell-based Drug DeliveryEngineering	2012	14

Page 1